XML 49 R36.htm IDEA: XBRL DOCUMENT
v3.20.2

Fair Value Measurements - Assets and Liabilities at Fair Value (Details) | 1 Months Ended | 3 Months Ended |
--- | --- | --- | ---
Jan. 31, 2010 contingentValueRight contingentValueRightSeries | Sep. 30, 2020 USD ($) | Jun. 30, 2020 USD ($) | Dec. 31, 2019 USD ($)
Assets: |  |  |  |
Short-term investments, excluding Viking |  | $ 297,704,000 |  | $ 939,989,000
Investment in Viking common stock |  | 33,869,000 |  | 48,425,000
Investment in warrants |  | 6,581,000 |  | 9,910,000
Total assets |  | 338,154,000 |  | 998,324,000
Liabilities: |  |  |  |
Amounts owed to former licensor |  | 71,000 |  | 75,000
Total liabilities |  | 10,869,000 |  | 9,017,000
Repayments of related party debt |  |  | $ 1,800,000 |
Number of CVR Series | contingentValueRightSeries | 4 |  |  |
Metabasis |  |  |  |
Liabilities: |  |  |  |
Number of CVRs issued per acquiree share | contingentValueRight | 4 |  |  |
Number of CVRs issued from each CVR series | contingentValueRight | 1 |  |  |
Frequency of cash payments to CVR holders | 6 months |  |  |
Transferred over Time | Phase 3 Clinical Trial |  |  |  |
Liabilities: |  |  |  |
Contract asset |  | 10,000,000 |  |
Maximum | Transferred over Time | Development, Regulatory, & Commercial Milestones and Tiered Royalties |  |  |  |
Liabilities: |  |  |  |
Investments |  | 375,000,000 |  |
Crystal contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 800,000 |  | 2,659,000
CyDex contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 509,000 |  | 348,000
Metabasis contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 4,985,000 |  | 5,935,000
Icagen contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 4,504,000 |  | 0
Payment for contingent liability |  | 500,000 |  |
Level 1 |  |  |  |
Assets: |  |  |  |
Short-term investments, excluding Viking |  | 2,274,000 |  | 3,073,000
Investment in Viking common stock |  | 33,869,000 |  | 48,425,000
Investment in warrants |  | 6,581,000 |  | 9,910,000
Total assets |  | 42,724,000 |  | 61,408,000
Liabilities: |  |  |  |
Amounts owed to former licensor |  | 71,000 |  | 75,000
Total liabilities |  | 71,000 |  | 75,000
Level 1 | Crystal contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 0 |  | 0
Level 1 | CyDex contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 0 |  | 0
Level 1 | Metabasis contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 0 |  | 0
Level 1 | Icagen contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 0 |  | 0
Level 2 |  |  |  |
Assets: |  |  |  |
Short-term investments, excluding Viking |  | 295,275,000 |  | 936,791,000
Investment in Viking common stock |  | 0 |  | 0
Investment in warrants |  | 0 |  | 0
Total assets |  | 295,275,000 |  | 936,791,000
Liabilities: |  |  |  |
Amounts owed to former licensor |  | 0 |  | 0
Total liabilities |  | 4,985,000 |  | 5,935,000
Level 2 | Crystal contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 0 |  | 0
Level 2 | CyDex contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 0 |  | 0
Level 2 | Metabasis contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 4,985,000 |  | 5,935,000
Level 2 | Icagen contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 0 |  | 0
Level 3 |  |  |  |
Assets: |  |  |  |
Short-term investments, excluding Viking |  | 155,000 |  | 125,000
Investment in Viking common stock |  | 0 |  | 0
Investment in warrants |  | 0 |  | 0
Total assets |  | 155,000 |  | 125,000
Liabilities: |  |  |  |
Amounts owed to former licensor |  | 0 |  | 0
Total liabilities |  | 5,813,000 |  | 3,007,000
Level 3 | Crystal contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 800,000 |  | 2,659,000
Level 3 | CyDex contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 509,000 |  | 348,000
Level 3 | Metabasis contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | 0 |  | 0
Level 3 | Icagen contingent liabilities |  |  |  |
Liabilities: |  |  |  |
Contingent liabilities |  | $ 4,504,000 |  | $ 0

X
- Definition Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders + References No definition available. + Details
Name: | lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders
Namespace Prefix: | lgnd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series + References No definition available. + Details
Name: | lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries
Namespace Prefix: | lgnd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Number of Contingent Value Rights Issued per Acquiree Share + References No definition available. + Details
Name: | lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare
Namespace Prefix: | lgnd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contingent Liabilities, Fair Value Disclosure + References No definition available. + Details
Name: | lgnd_ContingentLiabilitiesFairValueDisclosure
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of Contingent Value Rights Series + References No definition available. + Details
Name: | lgnd_NumberOfContingentValueRightsSeries
Namespace Prefix: | lgnd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payments to Contingent Value Right Holders and Other Contingency Payments, Investing Activities + References No definition available. + Details
Name: | lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Short-Term Investments, Fair Value Disclosure + References No definition available. + Details
Name: | lgnd_ShortTermInvestmentsFairValueDisclosure
Namespace Prefix: | lgnd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_AssetsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_AssetsFairValueDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044 + Details
Name: | us-gaap_ContractWithCustomerAssetGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740 + Details
Name: | us-gaap_EquitySecuritiesFvNi
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.1(h)) -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910 + Details
Name: | us-gaap_Investments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of financial and nonfinancial obligations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_LiabilitiesFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_LiabilitiesFairValueDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3(b)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_NotesReceivableFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of other liabilities. + References No definition available. + Details
Name: | us-gaap_OtherLiabilitiesFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |